...
首页> 外文期刊>Vaccine >Immunostimulatory effects of polar glycopeptidolipids of Mycobacteriumchelonae for inactivated rabies vaccine
【24h】

Immunostimulatory effects of polar glycopeptidolipids of Mycobacteriumchelonae for inactivated rabies vaccine

机译:犬分枝杆菌极性糖肽脂质对狂犬病灭活疫苗的免疫刺激作用

获取原文
获取原文并翻译 | 示例
           

摘要

Humoral and cellular immune responses were analyzed with Fuenzalida-Palacios rabies vaccine associated with pGPL-Mc, polar glycopeptidolipids extracted from Mycobacterium chelonae, aiming at its use as adjuvant. These results were compared to those obtained with BCG, a well-known immunostimulator, under the same conditions. Rabies vaccine plus pGPL-Mc (2.5 mg/ kg) induced a significant increase in serum neutralizing activity, in vitro lymphocyte proliferation (spontaneous, specific and mitogen stimulation) and delayed type hypersensibility. In addition, pGPL-Mc, as well as BCG, enhanced the Vaccine potency. Our results support further studies to encourage the use of pGPL-Mc as an immunostimulator of veterinary vaccines, before consideration for human vaccines.
机译:体液和细胞免疫应答用与pGPL-Mc相关的Fuenzalida-Palacios狂犬病疫苗进行了分析,pGPL-Mc是从chelonae分枝杆菌中提取的极性糖肽脂质,旨在用作佐剂。将这些结果与在相同条件下用著名的免疫刺激剂BCG获得的结果进行比较。狂犬病疫苗加pGPL-Mc(2.5 mg / kg)引起血清中和活性,体外淋巴细胞增殖(自发,特异性和促有丝分裂原刺激)和迟发型高敏性显着增加。另外,pGPL-Mc和BCG增强了疫苗效力。我们的结果支持进一步的研究,以鼓励在考虑使用人类疫苗之前鼓励使用pGPL-Mc作为兽用疫苗的免疫刺激剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号